166 related articles for article (PubMed ID: 3985123)
21. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
22. The nature and significance of tumour-associated mast cells.
Roche WR
J Pathol; 1986 Feb; 148(2):175-82. PubMed ID: 3950814
[TBL] [Abstract][Full Text] [Related]
23. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
24. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
26. Adoptive cell transfer of contact sensitivity-initiation mediated by nonimmune cells sensitized with monoclonal IgE antibodies. Dependence on host skin mast cells.
Matsuda H; Ushio H; Paliwal V; Ptak W; Askenase PW
J Immunol; 1995 May; 154(10):5080-92. PubMed ID: 7730614
[TBL] [Abstract][Full Text] [Related]
27. Mast cells and angiogenesis.
Hiromatsu Y; Toda S
Microsc Res Tech; 2003 Jan; 60(1):64-9. PubMed ID: 12500262
[TBL] [Abstract][Full Text] [Related]
28. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor.
Kops SK; Van Loveren H; Rosenstein RW; Ptak W; Askenase PW
Lab Invest; 1984 Apr; 50(4):421-34. PubMed ID: 6608629
[TBL] [Abstract][Full Text] [Related]
29. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
30. Mast cell interactions with the nervous system: relationship to mechanisms of disease.
Dines KC; Powell HC
J Neuropathol Exp Neurol; 1997 Jun; 56(6):627-40. PubMed ID: 9184654
[TBL] [Abstract][Full Text] [Related]
31. [The effect of immunomodulators that stimulate macrophagal functional activity on the morphofunctional characteristics of mast cells].
Bochkarev VA; Kupriianov VS
Tsitologiia; 1994; 36(9-10):960-5. PubMed ID: 7701624
[TBL] [Abstract][Full Text] [Related]
32. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
33. Modulation of tumor angiogenesis by stem cell factor.
Zhang W; Stoica G; Tasca SI; Kelly KA; Meininger CJ
Cancer Res; 2000 Dec; 60(23):6757-62. PubMed ID: 11118063
[TBL] [Abstract][Full Text] [Related]
34. Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen.
Luiten RM; Fleuren GJ; Warnaar SO; Litvinov SV
Lab Invest; 1996 Feb; 74(2):467-75. PubMed ID: 8780164
[TBL] [Abstract][Full Text] [Related]
35. Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor.
Izbicka E; Dunstan C; Esparza J; Jacobs C; Sabatini M; Mundy GR
Cancer Res; 1996 Feb; 56(3):633-6. PubMed ID: 8564983
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
Wiltrout RH; Frost P
J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
[No Abstract] [Full Text] [Related]
37. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
38. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions.
Hogaboam C; Kunkel SL; Strieter RM; Taub DD; Lincoln P; Standiford TJ; Lukacs NW
J Immunol; 1998 Jun; 160(12):6166-71. PubMed ID: 9637535
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
